| Association of circulating serum miR-34a and miR-122 with dyslipidemia among patients with non-alcoholic fatty liver disease NC Salvoza, DC Klinzing, J Gopez-Cervantes, MO Baclig PloS one 11 (4), e0153497, 2016 | 149 | 2016 |
| Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates N Salvoza, PJ Giraudi, C Tiribelli, N Rosso International Journal of Molecular Sciences 23 (5), 2764, 2022 | 48 | 2022 |
| Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease NC Salvoza, PJ Giraudi, C Tiribelli, N Rosso Exploration of Medicine 1 (2), 51-74, 2020 | 34 | 2020 |
| Complete genome sequence of chikungunya virus isolated in the Philippines KD Kawashima, LAC Suarez, HKM Labayo, VR Liles, NC Salvoza, ... Genome announcements 2 (3), 10.1128/genomea. 00336-14, 2014 | 16 | 2014 |
| The beneficial effects of triterpenic acid and acteoside in an in vitro model of nonalcoholic steatohepatitis (NASH) N Salvoza, C Bedin, A Saccani, C Tiribelli, N Rosso International journal of molecular sciences 23 (7), 3562, 2022 | 12 | 2022 |
| The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: Evidence from translational studies N Salvoza, P Giraudi, S Gazzin, D Bonazza, S Palmisano, N de Manzini, ... Journal of Translational Medicine 21 (1), 906, 2023 | 10 | 2023 |
| Ficolin-2 plasma level assesses liver fibrosis in non-alcoholic fatty liver disease PJ Giraudi, N Salvoza, D Bonazza, C Saitta, D Lombardo, B Casagranda, ... International Journal of Molecular Sciences 23 (5), 2813, 2022 | 9 | 2022 |
| Rat Liver Perfusion and Primary Hepatocytes Isolation: An Old Procedure Crucial for Cutting-Edge 3D Organoids Culture V Tiriticco, G Codotto, B Blarasin, N Salvoza, M Stebel, C Tiribelli, ... Journal of Visualized Experiments (JoVE), e66857, 2024 | | 2024 |
| Translational Approach for the Study of Metabolic-Associated Fatty Liver Disease (MAFLD): A Wide Spectrum Disease N Salvoza Università degli Studi di Trieste, 2023 | | 2023 |
| In silico identification and validation of plasma Ficolin-2 (FCN-2) as non-invasive biomarker of fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD) PJ Giraudi, N Salvoza, N Rosso, C Tiribelli, D Bonazza, B Casagranda, ... Journal of Hepatology 77, S433, 2022 | | 2022 |
| Alternative compounds to Nonalcoholic Steatohepatitis (NASH) treatment: in vitro evidence of triterpenic acids and phenylpropanoids N Salvoza, C Bedin, A Saccani, C TRIBELLI, N Rosso HEPATOLOGY 74, 1130A-1131A, 2021 | | 2021 |
| Anti-oxidant, anti-inflammatory, and anti-fibrotic properties of triterpenic acids and phenylpropanoids on in vitro models of non-alcoholic steatohepatitis N Salvoza, C Bedin, A Saccani, C Tiribelli, N Rosso JOURNAL OF HEPATOLOGY 75, S619-S619, 2021 | | 2021 |
| The potential role of Omentin-1 in Metabolic-Associated Fatty Liver Disease (MAFLD): Evidence from translational studies N SALVOZA, PJ GIRAUDI, S GAZZIN, D BONAZZA, S PALMISANO, ... Am. J. Physiol.-Endocrinol. Metab 290, E1253-E1261, 2006 | | 2006 |
| Supplementary Materials 1. Ficolin-2 plasma levels in the diagnosis of liver fibrosis in non-alcoholic fatty liver disease PJ Giraudi, N Salvoza, D Bonazza, C Saitta, D Lombardo, B Casagranda, ... | | |
